Financial release accessible
online
BOSTON, Nov. 7, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that
financial results for its second quarter fiscal year 2025, which
ended September 28, 2024, are
available on its Investor Relations website.
The Company will host a conference call and webcast with
investors and analysts to discuss and answer questions about the
results at 8:00 a.m. ET on
November 7, 2024. The conference call
and webcast can be accessed with the following information:
- Teleconference
link: https://register.vevent.com/register/BI3c9f473811f94c489025845778f9dabc
- Once registration is completed, participants will receive a
dial-in number along with a personalized PIN to access the call.
While not required, it is recommended that participants join 10
minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics'
investor relations website or via the following link:
https://edge.media-server.com/mmc/p/rcm5foqd
In addition, the Company has posted to its Investor Relations
website the earnings release that will be referenced on its
conference call and webcast, a link to which is available
below.
Direct link to 2Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/a28cb934-1e51-4489-9c9f-1a3f68dc7f5a
A replay of the conference call and webcast will be available
for one year beginning on November 7,
2024, at 11:00 a.m. ET using
the conference call webcast link provided in this press
release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global
healthcare company dedicated to providing a suite of innovative
medical products and solutions for customers, to help them improve
patient care and reduce the cost of healthcare. Our technology
addresses important medical markets: blood and plasma component
collection, the surgical suite and hospital transfusion services.
To learn more about Haemonetics, visit www.haemonetics.com.
|
Investor
Contacts:
|
|
|
Olga Guyette, Vice
President-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
|
(781)
356-9763
|
(203)
733-4987
|
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
Media
Contact:
|
|
|
Josh Gitelson, Sr.
Director-Global Communications
|
|
|
(781)
356-9776
|
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302298494.html
SOURCE Haemonetics Corporation